Integrative Oncology's 30-Year Anniversary: What Have We Achieved? A North American Naturopathic Oncology Perspective.
Integrative cancer therapies January 1, 2023 Leanna J Standish, Sonia M Malani, Ksenia Lynch et al. 5 citations
Over the past 30 years, integrative oncology has made valuable advances: intravenous high-dose ascorbate has clinical applications with certain chemotherapies; whole-body, extracorporeal, and locoregional hyperthermia are used for solid tumors including brain tumors; PDL-1 testing and immunotherapies show excellent outcomes in a subgroup of cancer patients; tumor DNA sequencing, including circulating tumor DNA, enables personalized precision treatments; better understanding of glucose metabolism has led to therapies like intermittent fasting and metformin; medical cannabis helps with chemotherapy side effects and shows anti-proliferative promise; psychoneuroendocrinoimmunology has expanded understanding of tumorigenesis and holistic immune regulation; psychedelic-assisted psychotherapy is gaining traction for cancer-related existential distress; spiritual health is now measurable with an NIH-validated scale; and mind-body therapies effectively reduce cancer-related distress.